Clinical Trial Update: Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating strategies to prevent contrast-induced nephropathy after transcatheter aortic valve replacement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Chronic Kidney Disease
• Contrast-induced Nephropathy
• Kidney Injury

Snippet

Sponsor: St. Antonius Hospital | Conditions: Aortic Valve Disease, Chronic Kidney Disease | Phase 4 | Status: UNKNOWN